Synendos Therapeutics Appoints Scientific Advisory Board

26/10/2021

Synendos Therapeutics Appoints Scientific Advisory Board Synendos Therapeutics (Synendos), a biopharmaceutical company focused on restoring the natural functioning of the endocannabinoid system to treat Central Nervous System (CNS) disorders, today announces the...

MinervaX provides clinical and leadership update

07/10/2021

MinervaX provides clinical and leadership update MinervaX, a privately held Danish biotechnology company developing a novel vaccine against Group B Streptococcus (GBS), today announces clinical progress on its maternal GBS vaccine as well as multiple additions to its...

US IPO: Value recognition? Not really! Trading liquidity? Yes!

06/10/2021

We previously looked at M&A of VC funded private and listed companies in the EU and US (https://bit.ly/3EU4n8H). Listing EU companies in the US is perceived as more attractive or beneficial – but is it reflected in the numbers?  Recently, we decided to take a...